BCLI logo

Brainstorm Cell Therapeutics Inc.


BCLI: Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Progressive Multiple Sclerosis (PMS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.


Show BCLI Financials

Consumer Interest
SEC Filings

Recent trades of BCLI by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by BCLI's directors and management

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Populations of mesenchymal stem cells that secrete neurotrophic factors Feb. 18, 2020
  • Patent Title: Methods of generating mesenchymal stem cells which secrete neurotrophic factors Aug. 14, 2018
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of BCLI in WallStreetBets Daily Discussion


Recent insights relating to BCLI

CNBC Recommendations

Recent picks made for BCLI stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in BCLI

Corporate Flights

Flights by private jets registered to BCLI